Table 3 PFKFB3 in different cancer cell lines
Cancer cell type | Upstream effector | Possible mechanism | PFKFB3 expression level | Effect on cancer cell | Ref. |
|---|---|---|---|---|---|
Breast cancer cells | Estradiol | Increased transcription of PFKFB3 by ER | ↑ | Survival, growth and metastases | |
|  | Progestins | Increased transcription of PFKFB3 by PR ERK/RSK phosphorylation of PFKFB3 | ↑ | Proliferation | |
|  | AMPK | Phosphorylation of PFKFB3 | — | Mitotic arrest survival | |
|  | miR-206 | Interaction with 3′UTR in PFKFB3 mRNA level | ↓ | Proliferation and migration inhibition | |
Hela cells | stress stimuli | p38/MK2 pathway | ↑ | Adaptation to microenvironmental conditions | |
|  | high ROS | S-glutathionylation of PFKFB3 | — | ROS detoxification; cell survival and proliferation | |
|  | MAPK14 | Increased degradation of PFKFB3 by APC/C-Cdh1 and SCF | ↓ | Increased resistance to nutrient deprivation | |
|  | siRNA | Silencing of PFKFB3 gene | ↓ | Cell cycle arrest at G1/S; Increased apoptosis; anchorage-independent growth | |
Pancreatic and gastric cancer cells | hypoxia | Increased transcription of PFKFB3 by HIF-1 | ↑ | Proliferation and survival | |
Colorectal cancer | IL-6 | — | ↑ | Proliferation and migration | |
Colon carcinoma cell lines |  | Phosphorylation PFKFB3 | — | Cell proliferation | |
|  | insulin | Increased transcription of PFKFB3 | ↑ |  | |
|  | siRNA | silencing of PFKFB3 gene | ↓ | Apoptosis | |
Lung adenocarcinoma cells | siRNA | Silencing of PFKFB3 gene | ↓ | Decreased growth | |
Renal cancer cells | rasfonin | — | ↑ | Autophagy and apoptosis | |
Myeloid lineage cells | JAK2/STAT5 | Increased transcription of PFKFB3 by STAT5 | ↑ | Increased Growth | |
Leukemia U937 cells | high ROS | Reduced methylation of PFKFB3 | — | Survive from oxidative stress | |
Acute myeloid leukemia cell lines | siRNA | Silencing of PFKFB3 gene | ↓ | Cell proliferation inhibition; apoptosis induction | |
DB-1 melanoma cells | low pH exposure | Phosphorylation PFKFB3 | — | Tumorigenesis and treatment resistance | |
Osteosarcoma cells | miR-26b | Interaction with 3′UTR in PFKFB3 mRNA level | ↓ | Proliferation, migration, invasion inhibition; apoptosis induction | |
Bladder cancer cell lines | 3PO | Inhibition of PFKFB3 | — | Reduced growth | |
Malignant hematopoietic and adenocarcinoma cell lines | 3PO | Inhibition of PFKFB3 | — | Reduced growth | |
Tongue cancer | 3PO | Inhibition of PFKFB3 | — | Proliferation inhibition, apoptosis | |
Pancreas cancer | TGFβ1 | Increased transcription of PFKFB3 | ↑ | Invasion | |
Gastric cancer cells | siRNA | Silencing of PFKFB3 gene | ↓ | Proliferation and migration inhibition | |
|  | PFK15 | Inhibition of PFKFB3 | — | Cell cycle arrest; apoptosis; invasion inhibition | |
Head and neck squamous cell carcinoma cell lines | PFK15 | Inhibition of PFKFB3 | — | Proliferation suppression; halted cell cycle progression; induced cell apoptosis | |
Glioblastoma cells |  | — | ↑(Induced) | Decreased growth rate, cell viability, anchorage-independent growth |